| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel | EVP &General Counsel
1 company
Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 41 sells.
Estimated insider holdings value: $20.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $229.27 | $1,375,605.32 | -3.8% | +8.5% | +64.7% | |
| Dec 7, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $238.89 | $1,433,330.59 | -7.6% | -2.1% | +52.7% | |
| Nov 16, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $226.60 | $1,359,592.76 | -3.8% | -5.4% | +60.3% | |
| Nov 2, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $225.76 | $1,354,553.96 | -3.0% | -5.9% | +63.9% | |
| Oct 19, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $225.43 | $1,352,591.23 | -3.8% | -1.6% | +63.2% | |
| Oct 5, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $223.82 | $1,342,922.80 | -3.7% | -0.0% | +55.9% | |
| Sep 21, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $222.19 | $1,333,150.20 | -3.8% | +0.8% | +57.8% | |
| Sep 7, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $222.98 | $1,337,904.69 | -5.0% | +7.8% | +55.2% | |
| Aug 17, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $229.54 | $1,377,265.02 | -3.7% | +0.5% | +40.7% | |
| Aug 3, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $236.25 | $1,417,470.05 | -2.2% | -3.4% | +41.3% |